PrecisionLife licenses OXEGENE dataset to develop personalized treatments for endometriosis

FHS
July 10, 2023
6:01 am

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

Abivax presents first-half 2024 financial results – Biotech Investments

EQS-News: ABIVAX / Key word(s): Half Year Results Abivax presents first-half 2024 financial results 09.09.2024 / 22:01 CET/CEST The issuer is solely responsible for the

September 10, 2024

Trump 2.0 spells uncertainty for US healthcare, says analyst – Pharmaceutical Technology

Former Republican presidential candidate Robert F. Kennedy Jr. and President-elect Donald Trump after RFK suspended his own campaign to endorse Trump in August 2024. Credit:

November 13, 2024

Lantheus hands Perspective Therapeutics $28M upfront to expand its radiopharma options

Radiopharma company Lantheus is looking to build up its portfolio through a collaboration with Perspective Therapeutics. By handing Perspective $28 million upfront, Lantheus has the

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.